Related Experiment Video
Updated: Aug 24, 2026

In Vivo Biosensor Tracks Non-apoptotic Caspase Activity in Drosophila
Published on: November 27, 2016
Kaurene diterpene induces apoptosis in human leukemia cells partly through a caspase-8-dependent pathway
Masuo Kondoh1, Ikue Suzuki, Masao Sato
1Department of Pharmaceutics and Biopharmaceutics, Showa Pharmaceutical University, Machida, Tokyo, 194-8543, Japan. masuo@ac.shoyaku.ac.jp
Abstract:
Defects in apoptosis signaling pathways contribute to tumorigenesis and drug resistance, and these defects are often a cause of failure of chemotherapy. Thus, a major goal in chemotherapy is to find cytotoxic agents that restore the ability of tumor cells to undergo apoptosis. We previously found that an Ent-kaurene diterpene, Ent-11alpha-hydroxy-16-kauren-15-one (KD), induced apoptosis in human promyelocytic leukemia HL-60 cells. Here, we found that caspase-8, an apoptotic factor, is involved in KD-induced apoptosis. Although treatment of HL-60 cells with KD resulted in the activation of caspase-8 and -9, a caspase-8-specific inhibitor but not a caspase-9-specific inhibitor attenuated KD-induced apoptosis. Expression of a catalytically inactive caspase-8 partly attenuated KD-induced apoptosis. Treatment with KD led to a time-dependent cleavage of Bid, a substrate of caspase-8, as well as to the proteolytic processing of procaspase-8, indicating that KD treatment induces apoptosis through a caspase-8-dependent pathway. Moreover, overexpression of the drug resistance factor Bcl-2, which is frequently overexpressed in many tumors, failed to confer resistance to KD-induced cytotoxicity. Thus, KD may be a promising experimental cytotoxic agent that possibly points to new strategies to overcome a drug resistance.
Insights
Ent-11alpha-hydroxy-16-kauren-15-one (KD) induces apoptosis in leukemia cells by activating caspase-8. This compound shows promise as a cytotoxic agent, potentially overcoming drug resistance in cancer therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Defects in apoptosis pathways drive cancer development and chemotherapy resistance.
- Identifying agents that restore apoptosis in tumor cells is crucial for effective cancer treatment.
Purpose of the Study:
- To investigate the mechanism of apoptosis induction by Ent-11alpha-hydroxy-16-kauren-15-one (KD) in human promyelocytic leukemia HL-60 cells.
- To determine the role of caspase-8 in KD-induced apoptosis and its potential to overcome drug resistance.
Main Methods:
- Treatment of HL-60 cells with KD.
- Assessing apoptosis induction and caspase activation (caspase-8 and -9).
- Utilizing caspase inhibitors and expressing catalytically inactive caspase-8.
- Analyzing Bid cleavage and procaspase-8 processing.
- Evaluating the effect of Bcl-2 overexpression on KD-induced cytotoxicity.
Main Results:
- KD treatment activated both caspase-8 and -9.
- A caspase-8 specific inhibitor, but not a caspase-9 inhibitor, attenuated KD-induced apoptosis.
- KD induced time-dependent Bid cleavage and procaspase-8 processing, confirming caspase-8 dependency.
- Overexpression of Bcl-2 did not confer resistance to KD, indicating its efficacy against drug-resistant factors.
Conclusions:
- KD induces apoptosis in HL-60 cells via a caspase-8-dependent pathway.
- KD demonstrates potential as a novel cytotoxic agent for overcoming cancer drug resistance.
- Further research into KD could lead to new therapeutic strategies for chemoresistant cancers.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Caspases
Apoptosis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cellular Injury V: Apoptosis and Autophagy